Metraipolis › archive › dc_449c5372f06e

UGT2B17 as a predictive biomarker of complete pathological response in HER2 + breast cancer — Europe PMC PMID:41790341

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41790341
DOI
10.1007/s12282-[numero omesso]-9
License (as archived)
solo-consultazione
Archived
2026-11-05T01:10:51.573Z
SHA-256 of the archived text
73ffa5b5ff7e2237d46004ca04e751aef8343d187f90b789222253a94db18a65
Stable URL of this page
https://metraipolis.com/documento/dc_449c5372f06e

How to cite

UGT2B17 as a predictive biomarker of complete pathological response in HER2 + breast cancer — Europe PMC PMID:41790341 — Europe PMC (en), https://europepmc.org/article/MED/41790341 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_449c5372f06e (Metraipolis archive dc_449c5372f06e, sha256 73ffa5b5ff7e2237d46004ca04e751aef8343d187f90b789222253a94db18a65)
BibTeX
@misc{dc449c5372f06e,
  title = {UGT2B17 as a predictive biomarker of complete pathological response in HER2 + breast cancer — Europe PMC PMID:41790341},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41790341},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_449c5372f06e; sha256 73ffa5b5ff7e2237d46004ca04e751aef8343d187f90b789222253a94db18a65},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41790341. Agents can read the archived copy with the MCP tool read_document.